Skip to Main Content

Author Details

Young Mog Shim
Samsung Medical Center, Sungkyunkwan University School of Medicine
1996
390
60
PMIDPaper TitleJournal TitlePublished Year
36608755Importance of Lymph Node Evaluation in ⿤2-cm Pure-Solid Non-Small Cell Lung Cancer.Ann Thorac Surg2024
38082188Prognostic role of pathologic status other than complete response after neoadjuvant therapy followed by surgery in esophageal squamous cell carcinoma.Esophagus2024
38082171Clinical and Pathologic Supraclavicular Lymph Node Metastases in Esophageal Squamous Cell Carcinoma Treated by Esophagectomy with Three-Field Lymph Node Dissection.Ann Surg Oncol2024
38062710Clinical Effect of Endosonography on Overall Survival in Patients with Radiological N1 Non-Small Cell Lung Cancer.Cancer Res Treat2024
37846467Neoadjuvant Nivolumab Therapy for Esophageal Squamous Cell Carcinoma: A Single-Arm, Phase II Study.Cancer Res Treat2024
37924973Clinical Significance of the Proposed Pathologic Criteria for Invasion by the International Association for the Study of Lung Cancer in Resected Nonmucinous Lung Adenocarcinoma.J Thorac Oncol2024
37814186Distinct Recurrence Pattern and Survival Outcomes of Invasive Mucinous Adenocarcinoma of the Lung: The Potential Role of Local Therapy in Intrapulmonary Spread.Ann Surg Oncol2024
37340844Clinical Validation of the Unparalleled Sensitivity of the Novel Allele-Discriminating Priming System Technology-Based EGFR Mutation Assay in Patients with Operable Non-Small Cell Lung Cancer.Cancer Res Treat2024
35166266Validation of the IASLC Residual Tumor Classification in Patients With Stage III-N2 Non-Small Cell Lung Cancer Undergoing Neoadjuvant Chemoradiotherapy Followed By Surgery.Ann Surg2023
37510453Unmet Supportive Care Needs after Non-Small Cell Lung Cancer Resection at a Tertiary Hospital in Seoul, South Korea.Healthcare (Basel)2023
37642118Factors associated with failure of cardiopulmonary function recovery after lung cancer surgery.Respirology2023
35681109The Role of Adjuvant Therapy Following Surgical Resection of Small Cell Lung Cancer: A Multi-Center Study.Cancer Res Treat2023
37054974Whole-Section Landscape Analysis of Molecular Subtypes in Curatively Resected Small Cell Lung Cancer: Clinicopathologic Features and Prognostic Significance.Mod Pathol2023
37114475The Role of Adjuvant Chemotherapy after Neoadjuvant Chemoradiotherapy Followed by Surgery in Patients with Esophageal Squamous Cell Carcinoma.Cancer Res Treat2023
37099712Lung cancer surgery for patients with reduced left ventricular ejection fraction: clinical outcomes and long-term survival.Eur J Cardiothorac Surg2023
36959680Metformin regulates expression of DNA methyltransferases through the miR-148/-152 family in non-small lung cancer cells.Clin Epigenetics2023
36753445Enhanced Recovery After Surgery Program and Opioid Consumption in Pulmonary Resection Surgery: A Retrospective Observational Study.Anesth Analg2023
36849852Different prognostic role of EGFR mutation according to the IASLC histological grade in patients with resected early-stage lung adenocarcinoma.Histopathology2023
36915249Diagnostic Performance of Endosonography to Detect Mediastinal Lymph Node Metastasis in Patients with Radiological N1 Non-Small Cell Lung Cancer.Cancer Res Treat2023
36397237Effectiveness of Self-Assessment, TAilored Information, and Lifestyle Management for Cancer Patients' Returning to Work (START): A Multi-center, Randomized Controlled Trial.Cancer Res Treat2023
36710577Surgery for Diaphragmatic Hernia Repair: A Longitudinal Single-Institutional Experience.J Chest Surg2023
36631064Adjuvant chemotherapy in node-positive patients after esophagectomy for esophageal squamous cell carcinoma.Thorac Cancer2023
35209702Psychometric Validation of the Korean Version of the Cancer Survivors' Unmet Needs (CaSUN) Scale among Korean Non-Small Cell Lung Cancer Survivors.Cancer Res Treat2023
33444764Thoracoscopic Vs Open Surgery Following Neoadjuvant Chemoradiation for Clinical N2 Lung Cancer.Semin Thorac Cardiovasc Surg2022
35740676The High Proportion of Discordant <i>EGFR</i> Mutations among Multiple Lung Tumors.Cancers (Basel)2022
35838647Clinical, Pathologic, and Molecular Prognostic Factors in Patients with Early-Stage EGFR-Mutant NSCLC.Clin Cancer Res2022
35370141An Overview of Surgical Treatment of Thymic Epithelial Tumors in Korea: A Retrospective Multicenter Analysis.J Chest Surg2022
35462111Prognostic impact of micropapillary and solid histological subtype on patients undergoing curative resection for stage I lung adenocarcinoma according to the extent of pulmonary resection and lymph node assessment.Lung Cancer2022
35462086Reclassifying the International Association for the Study of Lung Cancer Residual Tumor Classification According to the Extent of Nodal Dissection for NSCLC: One Size Does Not Fit All.J Thorac Oncol2022
35626242Risk Factors for the Development of Nontuberculous Mycobacteria Pulmonary Disease during Long-Term Follow-Up after Lung Cancer Surgery.Diagnostics (Basel)2022
35715654Reappraising the clinical usability of consolidation-to-tumor ratio on CT in clinical stage IA lung cancer.Insights Imaging2022
35847839Prognostic Significance of FDG PET/CT in Esophageal Squamous Cell Carcinoma in the Era of the 8th AJCC/UICC Staging System.Front Oncol2022
36418999Mortality and lung function decline in patients who develop chronic pulmonary aspergillosis after lung cancer surgery.BMC Pulm Med2022
36042472Longitudinal changes in pulmonary function and patient-reported outcomes after lung cancer surgery.Respir Res2022
36230875Clinical Trends in Management of Locally Advanced ESCC: Real-World Evidence from a Large Single-Center Cohort Study.Cancers (Basel)2022
35987831Role of intraoperative feeding jejunostomy in esophageal cancer surgery.J Cardiothorac Surg2022
35158205Adjuvant durvalumab for esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy: a placebo-controlled, randomized, double-blind, phase II study.ESMO Open2022
34970830The rarest of rare cases within the one thousand faces of atypical carcinoid: Pseudomesotheliomatous manifestation in a pregnant woman.Thorac Cancer2022
35115426Treatment of Refractory Chylous Ascites with an Innovative Peritoneovenous Shunt: Temporary Usage of a Continuous Renal Replacement System: A Case Report.J Chest Surg2022
35115420Surgical Strategy for Primary Colorectal Carcinoma and Synchronous Pulmonary Metastasis Resection.J Chest Surg2022
35115417Adjuvant Chemotherapy in Patients with Node-Negative Non-Small Cell Lung Cancer with Satellite Pulmonary Nodules in the Same Lobe.J Chest Surg2022
34996488Video-assisted thoracoscopic lobectomy versus open lobectomy in the treatment of large lung cancer: propensity-score matched analysis.J Cardiothorac Surg2022
35053460Aberrant Methylation of <i>SLIT2</i> Gene in Plasma Cell-Free DNA of Non-Small Cell Lung Cancer Patients.Cancers (Basel)2022
34698929Pragmatic role of noncontrast magnetic resonance lymphangiography in postoperative chylothorax or cervical chylous leakage as a diagnostic and preprocedural planning tool.Eur Radiol2022
34480274Role of Recurrent Laryngeal Nerve Lymph Node Dissection in Surgery of Early-Stage Esophageal Squamous Cell Carcinoma.Ann Surg Oncol2022
34155501The efficacy of adjuvant chemotherapy with capecitabine and cisplatin after surgery in locally advanced esophageal squamous cell carcinoma: a multicenter randomized phase III trial.Dis Esophagus2022
34365522Trimodality therapy for locally advanced esophageal squamous cell carcinoma: the role of volume-based PET/CT in patient management and prognostication.Eur J Nucl Med Mol Imaging2022
34289412Nononcologic Mortality after Pneumonectomy Compared to Lobectomy.Semin Thorac Cardiovasc Surg2022
33086317Conditional Survival of Patients Who Underwent Curative Resection for Esophageal Squamous Cell Carcinoma.Ann Surg2022
32736865Tumor size as a prognostic factor in limited-stage thymic epithelial tumors: A multicenter analysis.J Thorac Cardiovasc Surg2021
  • 1 - 50 of 390

Recommended Authors

The First Affiliated Hospital of Guangzhou Medical University
Career Start Year 2017
Number of shared co-authors 0
Institut de Pathologie Multisite
Career Start Year 2013
Number of shared co-authors 0
Peking University Cancer Hospital & Institute
Career Start Year 2012
Number of shared co-authors 0
Shanghai Children's Hospital, Shanghai Jiao Tong University
Career Start Year 2011
Number of shared co-authors 0
University of Texas MD Anderson Cancer Center
Career Start Year 2008
Number of shared co-authors 1
National Cancer Center Exploratory Oncology Research & Clinical Trial Center
Career Start Year 2008
Number of shared co-authors 0
Royal Melbourne Hospital
Career Start Year 2006
Number of shared co-authors 0
the First Affiliated Hospital of Guangzhou Medical University
Career Start Year 2006
Number of shared co-authors 0
Daegu Catholic University Medical Center
Career Start Year 2006
Number of shared co-authors 0
Peking University Cancer Hospital
Career Start Year 2005
Number of shared co-authors 0
the First Affiliated Hospital of Guangzhou Medical University
Career Start Year 2005
Number of shared co-authors 0
David Geffen School of Medicine, University of California Los Angeles
Career Start Year 2005
Number of shared co-authors 0
Memorial Sloan Kettering Cancer Center
Career Start Year 2005
Number of shared co-authors 1
Peking University People's Hospital
Career Start Year 2002
Number of shared co-authors 0
Peking University Cancer Hospital & Institute
Career Start Year 2002
Number of shared co-authors 0
University of Virginia
Career Start Year 2000
Number of shared co-authors 0
Yamagata Prefectural Central Hospital
Career Start Year 1998
Number of shared co-authors 0
Homi Bhabha National Institute
Career Start Year 1998
Number of shared co-authors 0
Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University
Career Start Year 1997
Number of shared co-authors 0
St Vincent's Hospital
Career Start Year 1997
Number of shared co-authors 4
Duke University Medical Center
Career Start Year 1996
Number of shared co-authors 0
Xuzhou Central Hospital
Career Start Year 1996
Number of shared co-authors 0
Mayo Clinic
Career Start Year 1996
Number of shared co-authors 2
St. Vincent's Hospital, University of Melbourne
Career Start Year 1995
Number of shared co-authors 4
Guangzhou Medical University, First Hospital
Career Start Year 1994
Number of shared co-authors 0
University of Toronto
Career Start Year 1988
Number of shared co-authors 1
New York-Presbyterian Hospital
Career Start Year 1983
Number of shared co-authors 1
University of California, USA Cardiovascular Research Institute san francisco
Career Start Year 1981
Number of shared co-authors 2
Catholic University
Career Start Year 1980
Number of shared co-authors 0
Duke University Medical Center
Career Start Year 1962
Number of shared co-authors 0

Collaborators

Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 112
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 12
Samsung Genome Institute, Samsung Medical Center
Co-authored papers 6
Seoul National University College of Medicine
Co-authored papers 6
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 5
Gangnam Severance Hospital
Co-authored papers 4
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 4
Samsung Medical Center, Sungkyunkwan University School
Co-authored papers 4
Asan Medical Center, University of Ulsan College of Medicine
Co-authored papers 3
College of Korean Medicine, Kyung Hee University
Co-authored papers 3
Yonsei Cancer Center, Yonsei University College of Medicine
Co-authored papers 3
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 3
Center for Nanophase Materials Sciences, Oak Ridge National Laboratory
Co-authored papers 3
Cancer Stem Cell Research Center, Samsung Biomedical Research Institute
Co-authored papers 2
Feinberg School of Medicine, Northwestern University
Co-authored papers 2
Co-authored papers 2
Yonsei University College of Medicine, Severance Hospital
Co-authored papers 2
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 2
Busan Paik Hospital, Inje University
Co-authored papers 2
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 2
Luxembourg Institute of Health
Co-authored papers 2
Center for Cancer Research, University of Tennessee Health Science Center
Co-authored papers 2
Institute for Refractory Cancer Research, Samsung Medical Center
Co-authored papers 2
Broad Institute
Co-authored papers 1
Broad Institute of MIT and Harvard
Co-authored papers 1
Inha University
Co-authored papers 1
Novartis Institutes for BioMedical Research
Co-authored papers 1
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 1
Oregon Health & Science University
Co-authored papers 1
Yale School of Medicine
Co-authored papers 1